<p>Concussions can cause long-term deficits in communication, according to findings from a study conducted by Assistant Professor Rocío Norman, PhD, CCC-SLP.</p>
Share This Story
<p>Lixin (Lee) Song, PhD, RN, FAAN, vice dean of research and scholarship at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) School of Nursing, has received a Translational Science and Technology Acquisition and Retention (STARs) award in the amount of $600,000 to renovate space to leverage her ongoing research […]</p>
Share This Story
<p>The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer. The U.S. Food and Drug Administration on Jan. 27 announced it approved the […]</p>
Share This Story
<p>Study will evaluate senolytics — drugs that clear defective ‘zombie’ cells A clinical trial conducted at UT Health San Antonio aims to “stomp” out Alzheimer’s disease. Clearing old, damaged “zombie” cells from the brain may be one way to do it. The study, called SToMP-AD (Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease), seeks 21 San […]</p>
Share This Story
<p>Thursday, January 26, 2023: Her Royal Highness Princess Maha Chakri Sirindhorn of Thailand, representing His Majesty the King Rama X Vajiralongkorn, presents the Prince Mahidol Award for 2022 in the field of medicine to Ralph A. DeFronzo, MD, of UT Health San Antonio and University Health. The presentation took place at the Chakri Throne Hall […]</p>
Share This Story
<p>Basic science generates new drug for treating glioblastoma, the deadliest cancer Glioblastoma multiforme (GBM) is an aggressive brain cancer associated with the worst overall survival rates among all human cancers. Only 65% of GBM patients live one year past diagnosis and only 12% live five years. The late senators Ted Kennedy and John McCain both […]</p>
Share This Story
<p>Study of jaw-joint sensory neurons aimed at creating safer pain treatment The UT Health San Antonio School of Dentistry has received a major five-year, $9.8 million grant from the National Institutes of Health to discover how sensory neurons in the jaw joint and mastication muscles influence and create pain, which could lead to safer drug […]</p>
Share This Story
<p>Vasan S. Ramachandran, MD, founding dean of The University of Texas School of Public Health San Antonio, a strategic collaboration between UT Health San Antonio and The University of Texas at San Antonio (UTSA), has received a UT System Faculty Science and Technology Acquisition and Retention (STARs) award for more than $1.6 million to fund […]</p>
Share This Story
<p>Drug target that revs up energy expenditure, reduces appetite identified A drug that promotes energy expenditure in the body while suppressing appetite could be a powerful weight loss therapy. Researchers at The University of Texas Health Science Center at San Antonio, the Second Xiangya Hospital of Central South University-China and Baylor College of Medicine reported […]</p>
Share This Story
<p>Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is an “accelerated approval” of the […]</p>
Share This Story